ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 8 filers reported holding ODONATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,335,000 | +27.8% | 989 | +175.5% | 0.00% | – |
Q3 2021 | $1,045,000 | -16.6% | 359 | 0.0% | 0.00% | – |
Q2 2021 | $1,253,000 | -82.4% | 359 | -82.8% | 0.00% | – |
Q1 2021 | $7,131,000 | -88.1% | 2,085 | -33.4% | 0.00% | – |
Q4 2020 | $60,077,000 | +41.2% | 3,129 | -1.2% | 0.00% | – |
Q3 2020 | $42,533,000 | +84.7% | 3,167 | +482.2% | 0.00% | – |
Q2 2020 | $23,033,000 | -72.2% | 544 | -81.9% | 0.00% | – |
Q1 2020 | $82,996,000 | +49.8% | 3,006 | +76.1% | 0.00% | – |
Q4 2019 | $55,392,000 | +31.0% | 1,707 | +5.1% | 0.00% | – |
Q3 2019 | $42,273,000 | +34.9% | 1,624 | +90.2% | 0.00% | – |
Q2 2019 | $31,333,000 | -1.7% | 854 | -40.8% | 0.00% | – |
Q1 2019 | $31,883,000 | +1921.8% | 1,442 | +1187.5% | 0.00% | – |
Q4 2018 | $1,577,000 | -62.0% | 112 | -47.7% | 0.00% | – |
Q3 2018 | $4,154,000 | -12.1% | 214 | 0.0% | 0.00% | – |
Q2 2018 | $4,725,000 | -81.8% | 214 | -82.6% | 0.00% | – |
Q1 2018 | $26,030,000 | – | 1,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
BESSEMER GROUP INC | 230 | $0 | 0.00% |